Polymerase delta interacting protein 2 sustains vascular structure and function

Arterioscler Thromb Vasc Biol. 2013 Sep;33(9):2154-61. doi: 10.1161/ATVBAHA.113.301913. Epub 2013 Jul 3.

Abstract

Objective: On the basis of previous evidence that polymerase delta interacting protein 2 (Poldip2) increases reduced nicotinamide adenine dinucleotide phosphate (NADPH) oxidase 4 (Nox4) activity in vascular smooth muscle cells, we hypothesized that in vivo knockdown of Poldip2 would inhibit reactive oxygen species production and alter vascular function.

Approach and results: Because homozygous Poldip2 deletion is lethal, Poldip2(+/-) mice were used. Poldip2 mRNA and protein levels were reduced by ≈50% in Poldip2(+/-) aorta, with no change in p22phox, Nox1, Nox2, and Nox4 mRNAs. NADPH oxidase activity was also inhibited in Poldip2(+/-) tissue. Isolated aortas from Poldip2(+/-) mice demonstrated impaired phenylephrine and potassium chloride-induced contractions, increased stiffness, and reduced compliance associated with disruption of elastic lamellae and excessive extracellular matrix deposition. Collagen I secretion was elevated in cultured vascular smooth muscle cells from Poldip2(+/-) mice and restored by H2O2 supplementation, suggesting that this novel function of Poldip2 is mediated by reactive oxygen species. Furthermore, Poldip2(+/-) mice were protected against aortic dilatation in a model of experimental aneurysm, an effect consistent with increased collagen secretion.

Conclusions: Poldip2 knockdown reduces H2O2 production in vivo, leading to increases in extracellular matrix, greater vascular stiffness, and impaired agonist-mediated contraction. Thus, unaltered expression of Poldip2 is necessary for vascular integrity and function.

Keywords: Nox4; Poldip2; blood vessel; extracellular matrix; hydrogen peroxide.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Aorta / drug effects
  • Aorta / metabolism*
  • Aorta / pathology
  • Aorta / physiopathology
  • Aortic Aneurysm / genetics
  • Aortic Aneurysm / metabolism
  • Aortic Aneurysm / pathology
  • Aortic Aneurysm / physiopathology
  • Aortic Aneurysm / prevention & control*
  • Blood Pressure
  • Cells, Cultured
  • Collagen Type I / metabolism
  • Cytochrome b Group / metabolism
  • Dilatation, Pathologic
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Elastic Tissue / metabolism
  • Extracellular Matrix / metabolism
  • Gene Expression Regulation
  • Genotype
  • Male
  • Membrane Glycoproteins / metabolism
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Mitochondrial Proteins / deficiency
  • Mitochondrial Proteins / genetics
  • Mitochondrial Proteins / metabolism*
  • Myocytes, Smooth Muscle / metabolism
  • NADH, NADPH Oxidoreductases / metabolism
  • NADPH Oxidase 1
  • NADPH Oxidase 2
  • NADPH Oxidase 4
  • NADPH Oxidases / metabolism
  • Nuclear Proteins / deficiency
  • Nuclear Proteins / genetics
  • Nuclear Proteins / metabolism*
  • Oxidants / pharmacology
  • Phenotype
  • RNA, Messenger / metabolism
  • Vascular Stiffness
  • Vasoconstrictor Agents / pharmacology
  • Vasodilation

Substances

  • Collagen Type I
  • Cytochrome b Group
  • Membrane Glycoproteins
  • Mitochondrial Proteins
  • Nuclear Proteins
  • Oxidants
  • RNA, Messenger
  • Vasoconstrictor Agents
  • mitogenin 1 protein, mouse
  • NADH, NADPH Oxidoreductases
  • Cybb protein, mouse
  • NADPH Oxidase 1
  • NADPH Oxidase 2
  • NADPH Oxidase 4
  • NADPH Oxidases
  • NOX1 protein, mouse
  • Nox4 protein, mouse
  • Cyba protein, mouse